We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » CDSCO Offers Guidance on Approval of Stem Cell/Cell-Based Products
CDSCO Offers Guidance on Approval of Stem Cell/Cell-Based Products
Manufacturers of stem cell and cell-based products (SCCPs) should perform stability tests during early phases of clinical trials to establish the products are sufficiently stable for the period required by the study, a draft guidance by India’s Central Drugs Standard Control Organization advises.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor